Controlled trial of budesonide–formoterol as needed for mild asthma
In double-blind, placebo-controlled trials, budesonide–formoterol used on an as-needed basis resulted in a lower risk of severe exacerbation of asthma than as-needed use of a short-acting β2-agonist (SABA); the risk was similar to that of budesonide maintenance therapy plus as-needed SABA. The availability of data from clinical trials designed to better reflect clinical practice would be beneficial.
We conducted a 52-week, randomized, open-label, par...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Pubs id:
- Local pid:
- Deposit date:
- Copyright holder:
- Massachusetts Medical Society
- Copyright date:
- © 2019 Massachusetts Medical Society. All rights reserved.
If you are the owner of this record, you can report an update to it here: Report update to this record